S&P Futures
3,944.25 -21.50 (-0.54%) Dow Futures
33,652.00 -151.00 (-0.45%) Nasdaq Futures
11,575.25 -70.25 (-0.60%) Russell 2000 Futures
1,806.60 -13.10 (-0.72%) Crude Oil
72.63 +1.17 (+1.64%) Gold
1,807.50 +6.00 (+0.33%)
High Fusion Inc. (2NU.F)
Chart Events
Performance Outlook
| Previous Close | 0.0005 |
| Open | 0.0035 |
| Bid | 0.0035 x N/A |
| Ask | 0.0105 x N/A |
| Day's Range | 0.0035 - 0.0035 |
| 52 Week Range | 0.0005 - 0.0550 |
| Volume | |
| Avg. Volume | 29 |
| Market Cap | 6.773M |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | 0.03 |
| EPS (TTM) | 0.1200 |
| Earnings Date | Nov 25, 2022 - Nov 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 2NU.F
Related Research
- Newsfile
High Fusion Announces Application for Management Cease Trade Order Is Denied
Toronto, Ontario--(Newsfile Corp. - November 17, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces that its request for a Management Cease Trade Order ("MCTO") was denied on November 16, 2022, by the Ontario Securities Commission ("OSC").Pursuant to National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), the Company notified OSC on November 15, 2022, that it anticipated a delay in filing its financial statements for ...
- Newsfile
High Fusion Announces Application for Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - November 15, 2022) - High Fusion Inc. (CSE: FUZN) (OTC Pink: SPLIF) ("High Fusion" or the "Company") announces today that it has made an application to the Ontario Securities Commission to approve a temporary management cease trade order ("MCTO") under National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which, if granted, will prohibit trading in securities of the Company by its Chief Executive Officer and Chief Financial Officer so long ...
- Newsfile
High Fusion and Its Psychedelics Subsidiary Neural Therapeutics Enter into Arrangement Agreement
Toronto, Ontario--(Newsfile Corp. - November 4, 2022) - High Fusion Inc. (CSE: FUZN) ("High Fusion" or the "Company") is pleased to announce that it has entered into a definitive arrangement agreement (the "Agreement") with Neural Therapeutics Inc. ("Neural") with respect to the distribution of a approximately one quarter of High Fusion's shareholdings in Neural to High Fusion shareholders ("Transaction").High Fusion CEO John Durfy commented, "This strategic spin-out of our holdings in Neural, f
